(Q54610810)

English

Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK. (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Behzad Molavi

1

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

Jiawei Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

J L Mehta

3

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

publication date

31 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

American Journal of Physiology Heart and Circulatory Physiology

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

291

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

2

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

H687-93

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Peroxisome proliferator-activated receptors in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

The angiotensin II type 2 receptor and improved adjacent region function post-MI.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

The angiotensin II type 2 receptor: an enigma with multiple variations

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

A Novel Action of Insulin on Cardiac Membrane

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Potentiation of insulin signaling in tissues of Zucker obese rats after acute and long-term treatment with PPARgamma agonists

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Angiotensin II-induced insulin resistance and protein tyrosine phosphatases

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Influence of angiotensin II type 1-receptor antagonist CV11974 on infarct size and adjacent regional function after ischemia-reperfusion in dogs

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Effect of chronic AT(1) receptor antagonism on postischemic functional recovery and AT(1)/AT(2) receptor proteins in isolated working rat hearts

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Regulation of angiotensin II-stimulated osteopontin expression in cardiac microvascular endothelial cells: role of p42/44 mitogen-activated protein kinase and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Role of AT2 receptors in the cardioprotective effect of AT1 antagonists in mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Troglitazone improves recovery of left ventricular function after regional ischemia in pigs

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00926.2005

21 January 2018

Identifiers

10.1152/AJPHEART.00926.2005

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 June 2018

http://europepmc.org/abstract/MED/16582019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54610810&oldid=1512254388"